The Future Is Now: Incorporating Telemedicine into Glaucoma Care.

IF 0.9 Q4 OPHTHALMOLOGY

Current Ophthalmology Reports Pub Date : 2021-01-01 Epub Date: 2021-07-07 DOI:10.1007/s40135-021-00269-x

Monica K Ertel, Malik Y Kahook, Cara E Capitena Young

{"title":"The Future Is Now: Incorporating Telemedicine into Glaucoma Care.","authors":"Monica K Ertel, Malik Y Kahook, Cara E Capitena Young","doi":"10.1007/s40135-021-00269-x","DOIUrl":null,"url":null,"abstract":"Purpose of review: The field of teleglaucoma has expanded rapidly in recent years with several large-scale teleglaucoma screening programs in existence throughout the world. Additionally, teleglaucoma programs for use in disease management are under study. The limited access to care that resulted from the COVID-19 pandemic highlighted the need for expansion of such programs. This article reviews the literature on teleglaucoma for screening and management of glaucoma, discussing considerations for incorporating teleglaucoma into clinical practice.Recent findings: Teleglaucoma screening reduces the rate of false-positive referrals and can accurately screen at-risk populations with accuracy similar to in-person screening. The use of teleglaucoma for the management of glaucoma shows promise for low-risk patients with early disease. Furthermore, teleglaucoma is cost-effective and reduces travel burden for patients resulting in high patient satisfaction.Summary: Teleglaucoma offers potential for improving access to glaucoma care, reducing the burden on patients and health care systems.","PeriodicalId":10836,"journal":{"name":"Current Ophthalmology Reports","volume":"9 3","pages":"88-95"},"PeriodicalIF":0.9000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s40135-021-00269-x","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Ophthalmology Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s40135-021-00269-x","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/7/7 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}

引用次数: 4

Abstract

Purpose of review: The field of teleglaucoma has expanded rapidly in recent years with several large-scale teleglaucoma screening programs in existence throughout the world. Additionally, teleglaucoma programs for use in disease management are under study. The limited access to care that resulted from the COVID-19 pandemic highlighted the need for expansion of such programs. This article reviews the literature on teleglaucoma for screening and management of glaucoma, discussing considerations for incorporating teleglaucoma into clinical practice.

Recent findings: Teleglaucoma screening reduces the rate of false-positive referrals and can accurately screen at-risk populations with accuracy similar to in-person screening. The use of teleglaucoma for the management of glaucoma shows promise for low-risk patients with early disease. Furthermore, teleglaucoma is cost-effective and reduces travel burden for patients resulting in high patient satisfaction.

Summary: Teleglaucoma offers potential for improving access to glaucoma care, reducing the burden on patients and health care systems.

查看原文本刊更多论文

未来就是现在:将远程医疗纳入青光眼护理。

综述目的:近年来，随着世界范围内的几个大型远光眼筛查项目的开展，远光眼的研究领域迅速扩大。此外，用于疾病管理的远端青光眼项目正在研究中。COVID-19大流行导致获得医疗服务的机会有限，这凸显了扩大此类规划的必要性。本文综述了有关远距青光眼筛查和治疗的文献，讨论了将远距青光眼纳入临床实践的注意事项。最近的发现:远青光眼筛查降低了假阳性转诊率，可以准确地筛查高危人群，其准确性与面对面筛查相似。使用远青光眼治疗青光眼对早期发病的低风险患者有很大的帮助。此外，远端青光眼具有成本效益，减少了患者的旅行负担，患者满意度高。摘要:远青光眼提供了改善获得青光眼护理的潜力，减轻了患者和卫生保健系统的负担。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Current Ophthalmology Reports Medicine-Ophthalmology

CiteScore

2.00

自引率

0.00%

发文量

期刊介绍： This journal aims to offer expert review articles on the most significant recent developments in the field of ophthalmology. By providing clear, insightful, balanced contributions, the journal intends to serve those who diagnose, treat, manage, and prevent ocular conditions and diseases. We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas across the field. Section Editors select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. An Editorial Board of more than 20 internationally diverse members reviews the annual table of contents, ensures that topics include emerging research, and suggests topics of special importance to their country/region. Topics covered may include age-related macular degeneration; diabetic retinopathy; dry eye syndrome; glaucoma; pediatric ophthalmology; ocular infections; refractive surgery; and stem cell therapy.